Why are US haemophilia A brands failing to stand out with physicians?
There are various options available to US haematologists treating haemophilia A. And most brands, it would seem, are having a torrid time in carving out loyalty and satisfaction with physicians. What are the key factors driving physician choice and how does each of the leading brands compare to its competitors?
NPS+ Haemophilia A (US) gives a unique insight into the overall brand health of 13 leading treatments for haemophilia A currently being used in North America. 100 haematologists were surveyed on key issues including brand messaging, prescribing behaviour and satisfaction levels. The results provide valuable insight for brand marketers seeking new ways to stand out.
Interested in the European market? Click here to see the EU5 Edition.
NPS+ Haemophilia A (US) offers valuable insight into brand loyalty from the perspective of those currently prescribing treatments for haemophilia A to patients. You’ll discover:
We surveyed 100 US-based haematologists chosen from the largest community of validated physicians in the world. We conducted the survey between April 5-12, 2018.
NPS is a customer loyalty metric developed by (and a registered trademark of) Fred Reichheld, Bain & Company, and Satmetrix. It was introduced by Reichheld in his 2003 Harvard Business Review article One Number You Need to Grow.
How does NPS work?
NPS measures overall brand satisfaction and loyalty by asking one simple question:
"How likely are you to recommend this brand to a colleague?"
Responses - given on a scale of 0 (not at all likely) to 10 (extremely likely)—are used to classify respondents into 3 categories:
Detractors are those who answer 0 – 6.
Passives are those who answer 7 – 8.
Promoters are those who answer 9 - 10.
How is NPS calculated?
The percentage of detractors - the percentage of promoters = NPS.
For example, 25% Promoters, 55% Passives and 20% Detractors give you an NPS of +5.
NPS can range from -100 (everybody is a Detractor) to +100 (everybody is a Promoter). The higher the score the healthier the brand.
At FirstWord, we stand behind our reports. If you're not completely satisfied, we’ll refund your money. Guaranteed.
FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence.
Learn more at www.firstwordgroup.com.
All Contents Copyright © 2019 Doctor's Guide Publishing Limited All Rights Reserved